COMMUNIQUÉS West-GlobeNewswire

Les résultats de XBiotech d’une étude randomisée de phase 1/2 en double aveugle suggèrent l’émergence d’un traitement révolutionnaire potentiel contre le cancer du pancréas avancé
19/06/2024
Les données indiquent des tendances vers une réduction des toxicités et de meilleurs résultats pour les sujets recevant l’association ONIVYDE/5-FU et une thérapie ciblée par anti-IL-1alpha AUSTIN, Texas, 19 juin 2024 ( [...]
Healthcare Integrated Technologies, Inc. Welcomes Dustin Hillis as Chief Strategy Officer
19/06/2024
Knoxville, Tennessee, June 19, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leader in developing advanced healthcare technology solutions, is thrilled to announce the appointment of [...]
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the Board of Directors Ready to Drive the Strategic Company’s Growth
19/06/2024
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the Board of Directors Ready to Drive the Strategic C ompany’s Growth Nantes, France – June 19, 2024, 6:15pm CET – OSE [...]
OSE Immunotherapeutics présente les résultats de l’Assemblée générale 2024 et l’évolution du Conseil d’administration prêt à conduire la stratégie de croissance de la Société
19/06/2024
OSE Immunotherapeutics présente les résultats de l’Assemblée générale 2024 et l’évolution du Conseil d’administration prêt à conduire la stratégie de croissance de la Société Nantes, France – le 19 juin 2024, 18 heures [...]
New Report Tracks Revenue Generated by Allied Healthcare Professionals
19/06/2024
Revenues May Exceed $2 Million Per Year After Staffing Costs DALLAS, June 19, 2024 (GLOBE NEWSWIRE) -- Allied health professionals such as radiology technologists and therapists can generate millions of dollars a year [...]
Rendever and Lenovo Collaborate to Bring Virtual Reality Experiences to Carolina Caring Seniors
19/06/2024
The joint project fuses Rendever’s platform with Lenovo’s ThinkReality VRX headset for an all-in-one VR approach that enhances the quality of life of older adults BOSTON, June 19, 2024 (GLOBE NEWSWIRE) -- Rendever , the [...]
Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)
19/06/2024
ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR ), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the [...]
Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association
19/06/2024
Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP) Investigators conclude that [...]
Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry
19/06/2024
LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of DCS Innovative Diagnostik-Systeme GmbH & Co. KG (“DCS” or the “Company”), a German supplier of reagents and [...]
Calibre Scientific fait l’acquisition de DCS, un fournisseur allemand spécialisé dans les anticorps, les réactifs et les équipements utilisés en immunohistochimie
19/06/2024
LOS ANGELES, 19 juin 2024 (GLOBE NEWSWIRE) -- Calibre Scientific a le plaisir d’annoncer l’acquisition de DCS Innovative Diagnostik-Systeme GmbH & Co. KG (« DCS » ou la « Société »), un fournisseur allemand [...]
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
19/06/2024
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]
Avicanna Announces USPTO Issuance of Patent SEDDS Technology
19/06/2024
Patent No. US 11,998,632 B2 (“Patent”) covers Avicanna’s self-emulsifying drug delivery system (“SEDDS”) oral cannabinoid composition and methods of treating neuropathic pain TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- [...]
Philips completes cancellation of 4.4 million shares
19/06/2024
June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the [...]
Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development
19/06/2024
Laboratory of Prof. Andrea Alimonti at IOR (Institute of Oncology Research, Bellinzona, Switzerland) and Macomics to bring together expertise on myeloid-derived suppressor cells in prostate cancer mouse model systems [...]
Nicox annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription sous forme d’ABSA d’un montant total de 3,3 millions d’euros et étend son horizon de trésorerie
19/06/2024
Communiqué de presse Nicox annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription sous forme d’ABSA d’un montant total de 3,3 millions d’euros et étend son horizon de [...]
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
19/06/2024
Fully underwritten Retail Entitlement Offer to open at 9:00 am (Melbourne time) on 19 June 2024 Retail Entitlement Offer to raise approximately A$55.0m (US$36.9m 1 ) will close at 5:00 pm (Melbourne time) on 10 July [...]
Cannabix Technologies Annual General and Special Meeting Results
19/06/2024
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common [...]
Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
19/06/2024
Webcasted conference call on Thursday, June 20, 2024 at 8:30 a.m. ET BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first [...]
Aptose Announces Results from Annual and Special Meeting of Shareholders
18/06/2024
SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]

Pages